Julie Perinel

Julie Perinel

Auto-generated profile, based on publicly available information

Julie Perinel

Department of Digestive Surgery, Hôpital Edouard Herriot, Lyon, France

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Translational Gastroenterology and Hepatology
Verified
Journal Article
Closed access
JPJulie Perinel
Julie Perinel
MAMustapha Adham
Mustapha Adham
Pancreatic cancer is a highly lethal disease with a dismal prognosis. It will probably become the second leading cause of cancer-related death within the next decade in Western countries. Over 80% of patients undergo palliative treatment for unresectable pancreatic cancer due to locally advanced disease or metastases. Those patients often develop gastric outlet obstruction (GOO), obstructive jaundice and pain during the course of their disease. Symptoms such as vomiting, anorexia, pruritus and jaundice will impact the quality of life (QOL) and could delay the administration of the chemotherapy. Palliative therapy in pancreatic cancer aims to relieve the symptoms durably and to improve the QOL. Palliative surgery was traditionally considered as a gold standard with the "double by-pass" including biliary-digestive and gastro-jejunal anastomosis. However, since the development of endoscopic stenting and minimally invasive surgery, the choice of the best modalities remains debated. While there is still a place for surgical gastrojejunostomy (GJ) in case of duodenal or GOO, endoscopic biliary stenting during endoscopic retrograde cholangiopancreatography (ERCP) is now accepted as the gold standard in case of obstructive jaundice. In pain management, endoscopic ultrasound guided or percutaneous celiac plexus neurolysis is recommended. The selection of the best technique should consider the effectiveness and the morbidity of the treatment, the performance status of the patient and the disease stage. While endoscopic stenting is associated with earlier recovery and shorter length of stay, recurrence of symptoms and reintervention are less frequent after palliative surgery. Finally, controversy exists on whether to perform prophylactic palliative surgery in the absence of symptoms when unresectable disease is discovered during surgical exploration.

24 May 2022 in Surgery
Verified
Journal Article
Closed access
JPJulie Perinel
Julie Perinel
GNGennaro Nappo
Gennaro Nappo
AZAlessandro Zerbi
Alessandro Zerbi
CHCharlotte M. Heidsma
Charlotte M. Heidsma
EDEls Nieveen van Dijkum
Els Nieveen van Dijkum
MAMustapha Adham
Mustapha Adham

16 January 2018 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
RSRegis Souche
Regis Souche
David FuksDavid Fuks
David Fuks
JPJulie Perinel
Julie Perinel
AHAstrid Herrero
Astrid Herrero
FGFrançoise Guillon
Françoise Guillon
JFJean-Michel Fabre
Jean-Michel Fabre

25 May 2024 in Surgery
Verified
Journal Article
Closed access
PAPietro Addeo
Pietro Addeo
PMPierre de Mathelin
Pierre de Mathelin
ADAlexandre Doussot
Alexandre Doussot
TDThibault Durin
Thibault Durin
GCGiulia Canali
Giulia Canali
MAMehdi El Amrani
Mehdi El Amrani

1 August 2019 in HepatoBiliary Surgery and Nutrition
Verified
Journal Article
Open access
PDF file
JPJulie Perinel
Julie Perinel
MAMustapha Adham
Mustapha Adham

4 June 2022
Verified
Book Chapter
Closed access
PDF file
JPJulie Perinel
Julie Perinel
MAMustapha Adham
Mustapha Adham